Free Trial

Lantern Pharma (LTRN) Earnings Date, Estimates & Call Transcripts

Lantern Pharma logo
$3.31
+0.19 (+6.09%)
(As of 11/1/2024 ET)

Lantern Pharma Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 7After Market ClosesConfirmed
Actual EPS
(Aug. 8)
-$0.46 Beat By $0.09
Consensus EPS
(Aug. 8)
-$0.55

Lantern Pharma released Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.46, which beat the consensus estimate of -$0.55 by $0.09. With a trailing EPS of -$1.65, Lantern Pharma's earnings are expected to grow next year, from ($2.12) to ($2.02) per share.

LTRN Upcoming Earnings

Lantern Pharma's next earnings date is scheduled for Thursday, November 7, 2024, with a conference call scheduled for at 4:30 PM ET. Interested parties can register for or listen to the call.

Get Lantern Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lantern Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LTRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LTRN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lantern Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.43-$0.43-$0.43
Q2 20241-$0.48-$0.48-$0.48
Q3 20242-$0.56-$0.54-$0.55
Q4 20242-$0.60-$0.59-$0.60
FY 20246($2.07)($2.04)($2.06)

Lantern Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Confirmed)
-------  
8/8/2024Q2 2024-$0.55-$0.46+$0.09-$0.46--        
5/9/2024Q1 2024-$0.43-$0.51 -$0.08-$0.51--    
3/18/2024Q4 2023-$0.40-$0.39+$0.01-$0.39--    
11/8/2023Q3 2023-$0.46-$0.29+$0.17-$0.29--    
8/9/2023Q2 2023-$0.40-$0.44 -$0.04-$0.44--        
5/9/2023Q1 2023--$0.36 -$0.36-$0.36--    
3/20/2023Q4 2022-$0.49-$0.31+$0.18-$0.31--    
11/7/2022Q3 2022-$0.54-$0.21+$0.33-$0.21--    

Lantern Pharma Earnings - Frequently Asked Questions

Lantern Pharma has confirmed that its next quarterly earnings data will be published on Thursday, November 7th, 2024. Learn more on LTRN's earnings history.

In the previous quarter, Lantern Pharma (NASDAQ:LTRN) reported ($0.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.09. Learn more on analysts' earnings estimate vs. LTRN's actual earnings.

The conference call for Lantern Pharma's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Lantern Pharma's latest earnings report can be read online.
Read Transcript

Lantern Pharma (NASDAQ:LTRN) has a recorded net income of -$15.96 million. LTRN has generated -$1.65 earnings per share over the last four quarters.

Lantern Pharma's earnings are expected to grow from ($2.12) per share to ($2.02) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:LTRN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners